Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector

Sarclisa SC approved in EU: first anticancer via on-body injector CirCLIQ®. Flexible home/clinic administration for multiple myeloma patients.

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.